Phage-derived polysaccharide depolymerase potentiates ceftazidime efficacy against Acinetobacter baumannii pneumonia via low-serum-dependent mechanisms
- 9 November 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 6) , 137486
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Arginine‐Enhanced Antimicrobial Activity of Nanozymes against Gram‐Negative BacteriaAdvanced Healthcare Materials, 2023
- Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospectsActa Pharmaceutica Sinica B, 2023
- Exploiting phage-derived carbohydrate depolymerases for combating infectious diseasesTrends in Microbiology, 2022
- Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutionsJournal of Biosciences, 2021
- N‐Terminal Protein Labeling with N‐Hydroxysuccinimide Esters and Microscale Thermophoresis Measurements of Protein‐Protein Interactions Using Labeled ProteinCurrent Protocols, 2021
- Structural and Functional Studies of a Klebsiella Phage Capsule Depolymerase Tailspike: Mechanistic Insights into Capsular DegradationStructure, 2020
- Surfactant induces ROS-mediated cell membrane permeabilization for the enhancement of mannatide productionProcess Biochemistry, 2020
- Alternatives to Conventional Antibiotics in the Era of Antimicrobial ResistanceTrends in Microbiology, 2019
- Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility TestingEBioMedicine, 2017
- Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: Risk factors, clinical features, and outcomesAmerican Journal of Infection Control, 2014